X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (911) 911
Publication (131) 131
Newspaper Article (97) 97
Book Chapter (9) 9
Conference Proceeding (8) 8
Book Review (7) 7
Patent (5) 5
Dissertation (2) 2
Book / eBook (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (320) 320
index medicus (319) 319
hematology (251) 251
male (204) 204
female (200) 200
middle aged (187) 187
aged (178) 178
multiple myeloma (173) 173
adult (150) 150
oncology (135) 135
survival (109) 109
aged, 80 and over (96) 96
multiple myeloma - drug therapy (94) 94
prognosis (93) 93
treatment outcome (87) 87
analysis (85) 85
article (82) 82
bortezomib (82) 82
stem-cell transplantation (81) 81
transplantation (80) 80
therapy (73) 73
care and treatment (68) 68
abridged index medicus (67) 67
dexamethasone (67) 67
retrospective studies (62) 62
diagnosis (61) 61
amyloidosis (59) 59
multiple myeloma - mortality (59) 59
multiple myeloma - pathology (57) 57
cancer (56) 56
multiple myeloma - therapy (56) 56
risk factors (53) 53
antineoplastic combined chemotherapy protocols - therapeutic use (51) 51
chemotherapy (50) 50
multiple-myeloma (50) 50
survival analysis (50) 50
research (47) 47
stem cells (46) 46
multiple myeloma - diagnosis (44) 44
patient outcomes (44) 44
transplantation, autologous (41) 41
disease-free survival (40) 40
patients (40) 40
stem cell transplantation (40) 40
survival rate (40) 40
follow-up studies (39) 39
lenalidomide (39) 39
disease progression (37) 37
thalidomide - analogs & derivatives (37) 37
al amyloidosis (36) 36
geosciences, multidisciplinary (36) 36
melphalan (36) 36
monoclonal gammopathy (36) 36
dexamethasone - administration & dosage (35) 35
myeloma (35) 35
primary systemic amyloidosis (35) 35
thalidomide (33) 33
medicine, general & internal (32) 32
multiple myeloma - genetics (32) 32
immunology (30) 30
hematopoietic stem cell transplantation (29) 29
bone marrow (28) 28
health aspects (28) 28
hematology, oncology and palliative medicine (28) 28
antineoplastic agents - therapeutic use (27) 27
hemic and lymphatic diseases (26) 26
undetermined significance (26) 26
apoptosis (25) 25
combined modality therapy (25) 25
recurrence (25) 25
thalidomide - administration & dosage (25) 25
amyloidosis - therapy (24) 24
clinical trials and observations (24) 24
drug therapy (24) 24
kaplan-meier estimate (24) 24
medical research (24) 24
usage (24) 24
geochemistry (23) 23
high-dose therapy (23) 23
progression (23) 23
risk (23) 23
autografts (22) 22
internal medicine (22) 22
medicine, experimental (22) 22
apoptosis - drug effects (21) 21
cell line, tumor (21) 21
development and progression (21) 21
high-dose melphalan (21) 21
india (21) 21
lenalidomide plus dexamethasone (21) 21
medicine & public health (21) 21
multiple myeloma - blood (21) 21
amyloidosis - mortality (20) 20
immunoglobulins (20) 20
original (20) 20
zirconium (20) 20
animals (19) 19
criteria (19) 19
expression (19) 19
international staging system (19) 19
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 09/2019, Volume 125, Issue 17, pp. 2920 - 2922
With the improving survival of patients with myeloma, there is a need for the development of multiple different drug combinations for continued treatment and... 
myeloma | daratumumab | relapse | efficacy | retreatment | SURVIVAL | ONCOLOGY | IMMUNOMODULATORY DRUGS | BORTEZOMIB | INHIBITORS | IMIDS | Clinical trials | Myeloma | Disease control | Medical treatment | New combinations | Multiple myeloma
Journal Article
Cancer journal (Sudbury, Mass.), ISSN 1528-9117, 01/2019, Volume 25, Issue 1, pp. 59 - 64
Journal Article
HAEMATOLOGICA, ISSN 0390-6078, 09/2019, Volume 104, Issue 10, pp. 2061 - 2074
Despite recent advances in the treatment of multiple myeloma, patients with this disease still inevitably relapse and become refractory to existing therapies.... 
CELLS | SIGNALING PATHWAYS | CONTRIBUTE | PHOSPHORYLATION | RAS MUTATIONS | VENETOCLAX | MCL-1 | STABILITY | MECHANISMS | HEMATOLOGY | HDAC
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1772 - 1772
Introduction: While the molecular target of immunomodulators such as pomalidomide (POM) and lenalidomide (LEN) has been identified, the mechanisms underlying... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3070 - 3070
Introduction: Recent advancements in the treatment of multiple myeloma (MM) have centered on engaging the immune system to target multiple myeloma cells.... 
Journal Article
Journal of Oncology Practice, ISSN 1554-7477, 07/2018, Volume 14, Issue 7, pp. 423 - 424
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3061 - 3061
Introduction: High-risk multiple myeloma can be defined by the presence of specific cytogenetic abnormalities (structural) or by characteristic changes in bone... 
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 13, pp. 1503 - 1512
Journal Article
Journal Article
Journal Article